The Patent Finder

Virxsys Corporation

Also on record
Records under this name other than patents Virxsys Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Virxsys Corporation

PatentTitleStatus Expires Confidence
US 8,053,232Correction of alpha-1-antitrypsin genetic defects using spliceosome mediated RNA trans splicing
Lapsed on the fee record
Ended Nov 8, 2019 · From the USPTO record
Lapsed on the fee recordEnded Nov 8, 2019From the USPTO record
US 7,968,334Expression of apoAI and variants thereof using spliceosome mediated RNA trans-splicing
Lapsed on the fee record
Ended Jun 28, 2019 · From the USPTO record
Lapsed on the fee recordEnded Jun 28, 2019From the USPTO record
US 7,879,321Use of RNA trans-splicing for antibody gene transfer and antibody polypeptide production
Lapsed on the fee record
Ended Feb 1, 2019 · From the USPTO record
Lapsed on the fee recordEnded Feb 1, 2019From the USPTO record
US 7,871,795Targeted trans-splicing of highly abundant transcripts for in vivo production of recombinant proteins
Lapsed on the fee record
Ended Jan 18, 2019 · From the USPTO record
Lapsed on the fee recordEnded Jan 18, 2019From the USPTO record
US 8,883,753Expression of apoAI and variants thereof using spliceosome mediated RNA trans-splicing
Lapsed on the fee record
Ended Nov 11, 2018 · From the USPTO record
Lapsed on the fee recordEnded Nov 11, 2018From the USPTO record
US 6,280,978Methods and compositions for use in spliceosome mediated RNA trans-splicing
Term ended
Term ended Sep 23, 2018 · From the USPTO record
Term endedTerm ended Sep 23, 2018From the USPTO record
US 7,094,399Use of spliceosome mediated RNA trans-splicing to confer cell selective replication to adenoviruses
Lapsed on the fee record
Ended Aug 22, 2018 · From the USPTO record
Lapsed on the fee recordEnded Aug 22, 2018From the USPTO record
US 6,083,702Methods and compositions for use in spliceosome mediated RNA trans-splicing
Term ended
Term ended Aug 13, 2018 · From the USPTO record
Term endedTerm ended Aug 13, 2018From the USPTO record
US 6,835,568Regulated nucleic acid expression system
Lapsed on the fee record
Ended Dec 28, 2016 · From the USPTO record
Lapsed on the fee recordEnded Dec 28, 2016From the USPTO record
US 6,013,487Chimeric RNA molecules generated by trans-splicing
Term ended
Term ended Dec 13, 2016 · From the USPTO record
Term endedTerm ended Dec 13, 2016From the USPTO record
10 of 14 patents shown.
Pro members see all 14.
Pro members: see all 14 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited